Home » Targacept’s ADHD Drug Fails Midstage Trial
Targacept’s ADHD Drug Fails Midstage Trial
Targacept said its experimental drug to treat attention deficit hyperactivity disorder in adults failed to meet the main goal of a mid-stage trial, sending its shares down as much as 6 percent.
London South East
London South East
Upcoming Events
-
07May
-
14May
-
30May